trending Market Intelligence /marketintelligence/en/news-insights/trending/1DuEIS9YtYgqPNtEWzjkUA2 content esgSubNav
In This List

Skyline Medical exploring merger with CytoBioscience

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Skyline Medical exploring merger with CytoBioscience

Skyline Medical Inc. is exploring a merger with privately held CytoBioscience Inc., a Texas-based healthcare manufacturer and contract research organization.

The companies have entered a so-called letter of intent to explore a merger. Assuming the parties enter a definitive agreement, the transaction would close by Sept. 30.

CytoBioscience has reported a current backlog of $6 million in orders and anticipated contract research work.